SynthesisTargeted oncology2022

Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis.

Evangelos Digkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.